,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,80415,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,155,1,1,,413543,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
2,157,1,1,,80415,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
3,157,1,1,,413543,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
4,161,1,1,,80415,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
5,161,1,1,,413543,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
6,165,1,1,,80415,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
7,165,1,1,,413543,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
8,167,1,1,,80415,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
9,167,1,1,,413543,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
10,175,1,1,,80415,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
11,175,1,1,,413543,836,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
12,248,1,1,,413543,836,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
13,578,2,2,,8034053,836,Inactive,61354647.0,,,,Literature data for small-molecule inhibitors of EGF-R_Tyrosine _Kinase_Homo_sapiens,Other,2552117.0,
14,875,1,2,,26749098,836,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
15,880,2,1,,26749098,836,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
16,880,2,1,,26749098,836,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
17,881,2,2,,26749098,836,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
18,884,1,2,,26749098,836,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
19,885,1,2,,26749098,836,Inactive,13435386.0,1576.0,,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
20,887,1,2,,26749098,836,Active,1832253.0,246.0,3.9811,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
21,889,1,3,,26749098,836,Inconclusive,1730092.0,840.0,15.8489,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
22,892,1,2,,26749098,836,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
23,893,1,2,,26749098,836,Active,122921310.0,,12.5893,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
24,893,1,2,,26749098,836,Active,122921311.0,,12.5893,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
25,894,2,1,,26749098,836,Inconclusive,31542939.0,3248.0,14.1254,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
26,900,1,3,,26749098,836,Inconclusive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
27,902,1,2,,26749098,836,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
28,910,1,2,,26749098,836,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 654 locus,Confirmatory,,
29,923,1,2,,26749098,836,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
30,924,1,2,,26749098,836,Inactive,120407068.0,7157.0,,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
31,927,1,3,,26749098,836,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
32,930,1,2,,26749098,836,Inactive,4504349.0,3043.0,,Potency,Confirmation and Secondary Assay for Modulators of Hemoglobin Beta Chain Splicing at IVS2 705 locus,Confirmatory,,
33,995,1,2,,26749098,836,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
34,1030,2,1,,26749098,836,Inconclusive,30582681.0,216.0,17.7828,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
35,1189,1,5,,48413701,836,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
36,1208,1,3,,48413701,836,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
37,1379,1,2,,26749098,836,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
38,1452,1,1,,26749098,836,Inactive,154426292.0,239.0,39.8107,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
39,1454,1,1,,26749098,836,Inconclusive,66932916.0,5594.0,25.1189,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
40,1457,1,1,,26749098,836,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
41,1458,1,1,,26749098,836,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
42,1460,1,3,,26749098,836,Active,92096784.0,4137.0,11.2202,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
43,1463,1,1,,26749098,836,Active,,,17.7828,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
44,1467,1,3,,26749098,836,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
45,1468,1,1,,26749098,836,Active,92096784.0,4137.0,25.1189,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
46,1469,1,1,,26749098,836,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
47,1471,2,1,,26749098,836,Unspecified,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
48,1476,2,1,,26749098,836,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
49,1478,2,1,,26749098,836,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
50,1479,1,2,,26749098,836,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
51,1490,2,1,,26749098,836,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
52,1519,1,3,,26749098,836,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
53,1766,1,1,,26749098,836,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
54,1766,1,1,,26749098,836,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
55,1768,1,1,,26749098,836,Inconclusive,18860839.0,4221.0,11.2202,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
56,1768,1,1,,26749098,836,Inconclusive,56550039.0,4297.0,11.2202,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
57,1865,1,1,,26749098,836,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
58,1948,1,1,,26749098,836,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
59,2062,1,2,,85209935,836,Active,,,,,Ligands of bioamine (Class A) GPCRs,Other,,
60,2101,1,1,,26749098,836,Inactive,496369.0,2629.0,,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
61,2107,1,1,,26749098,836,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
62,2112,1,1,,26749098,836,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
63,2147,1,1,,26749098,836,Inconclusive,221046486.0,,12.5893,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
64,2451,1,2,,26749098,836,Active,122920737.0,,15.8114,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
65,2472,1,2,,26749098,836,Active,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
66,2517,2,1,,26749098,836,Active,6980812.0,,0.2818,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
67,2528,1,2,,26749098,836,Active,4557365.0,641.0,8.9125,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
68,2546,1,1,,26749098,836,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
69,2549,1,1,,26749098,836,Active,282403581.0,,2.5119,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
70,2551,1,1,,26749098,836,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
71,2564,1,1,,26749098,836,Inconclusive,,,35.4813,Potency,Counterscreen for APE1 Inhibitors: Fluorescent Dye Displacement Assay,Confirmatory,,
72,2565,1,1,,26749098,836,Inactive,405898.0,,1.9953,Potency,Counterscreen for APE1 Inhibitors: qHTS Assay for Inhibitors of Endonuclease IV,Confirmatory,,
73,2572,1,1,,26749098,836,Active,6980812.0,,0.1585,Potency,Confirmation qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
74,2573,1,1,,26749098,836,Inactive,6980812.0,,,Potency,qHTS FP-Based Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
75,2708,1,1,,26749098,836,Inactive,282403581.0,,,Potency,Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
76,2711,1,1,,26749098,836,Inconclusive,,,39.8107,Potency,Counterscreen for RECQ1 Inhibitors: ADP Fluorescence Polarization Displacement Assay,Confirmatory,,
77,2712,1,1,,26749098,836,Inconclusive,,,39.8107,Potency,Counterscreen for BLMA Inhibitors: ADP Fluorescence Polarization Displacement Assay,Confirmatory,,
78,307315,6,2,,103411173,836,Unspecified,,,500.0,IC50,Inhibition of p56lck SH2 domain by ELISA,Confirmatory,17418581.0,
79,307316,3,4,,103411173,836,Unspecified,,,,,Inhibition of Jurkat cell activation assessed as blocking of T-cell antigen receptor-induced IL-2 expression at 10 uM by luciferase assay,Other,17418581.0,
80,485290,1,1,,26749098,836,Inconclusive,20150581.0,,0.1259,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
81,504370,1,1,,26749098,836,Inconclusive,13124873.0,865.0,28.1838,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation,Confirmatory,,
82,504370,1,1,,26749098,836,Inconclusive,49574546.0,861.0,28.1838,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: ME-1 cellular proliferation,Confirmatory,,
83,504374,2,1,,26749098,836,Active,13124873.0,865.0,1.122,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation,Confirmatory,,
84,504374,2,1,,26749098,836,Active,49574546.0,861.0,1.122,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation,Confirmatory,,
85,504375,1,2,,26749098,836,Active,13124873.0,865.0,0.8913,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay,Confirmatory,,
86,504375,1,2,,26749098,836,Active,49574546.0,861.0,0.8913,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia: Hit Validation with Orthogonal Assay,Confirmatory,,
87,588579,1,1,,124879975,836,Active,7705344.0,51426.0,0.1585,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
88,602332,1,1,,124879975,836,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
89,686978,1,1,,124879975,836,Active,79154014.0,55775.0,2.9093,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
90,686979,1,1,,124879975,836,Active,79154014.0,55775.0,3.6626,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
91,720532,1,1,,124879975,836,Active,420597.0,,1.5849,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
92,720533,1,1,,124879975,836,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
93,720579,2,1,,124879975,836,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
94,720580,1,1,,124879975,836,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
95,781326,1,2,,103411173,836,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X,Other,24249037.0,
96,1159524,1,1,,124879975,836,Inactive,,,,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
97,1159580,2,1,,273002802,836,Inactive,,,,,"The chemical genetic matrix (CGM) dataset as reported in Wildenhain et al. (2015) Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. Cell Systems Volume 1, Issue 6, p383-395",Summary,,
98,1194150,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as hydroxyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
99,1194151,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as rate constant for hydroxyl radical scavenging activity using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
100,1194152,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as superoxide anion radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
101,1194153,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as rate constant for superoxide anion radical scavenging activity using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
102,1194154,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as alkoxyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
103,1194155,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as rate constant for alkoxyl radical scavenging activity using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
104,1194156,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as peroxyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
105,1194157,1,1,,103411173,836,Inconclusive,,,,,Antioxidant activity assessed as rate constant for peroxyl radical scavenging activity using CYPMPO spin trap by ESR spin-trapping method,Other,25791448.0,
106,1194158,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as methyl radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
107,1194159,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as rate constant for methyl radical scavenging activity using DMPO spin trap by ESR spin-trapping method,Other,25791448.0,
108,1194160,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as singlet oxygen radical scavenging activity by measuring relative rate constant (kAOx/kST ratio) using 4-HO-TEMP spin trap by ESR spin-trapping method,Other,25791448.0,
109,1194161,1,1,,103411173,836,Unspecified,,,,,Antioxidant activity assessed as rate constant for singlet oxygen radical scavenging activity using 4-HO-TEMP spin trap by ESR spin-trapping method,Other,25791448.0,
